131 related articles for article (PubMed ID: 10825480)
1. Calretinin-containing axons and neurons are resistant to an intrastriatal 6-hydroxydopamine lesion.
Tsuboi K; Kimber TA; Shults CW
Brain Res; 2000 Jun; 866(1-2):55-64. PubMed ID: 10825480
[TBL] [Abstract][Full Text] [Related]
2. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages.
Aoi M; Date I; Tomita S; Ohmoto T
Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110
[TBL] [Abstract][Full Text] [Related]
3. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
4. Axonal expression sites of tyrosine hydroxylase, calretinin- and calbindin-immunoreactivity in striato-pallidal and septal nuclei of the rat brain: a double-immunolabelling study.
Seifert U; Härtig W; Grosche J; Brückner G; Riedel A; Brauer K
Brain Res; 1998 Jun; 795(1-2):227-46. PubMed ID: 9622641
[TBL] [Abstract][Full Text] [Related]
5. On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat.
Tan Y; Williams EA; Lancia AJ; Zahm DS
Brain Res; 2000 Jun; 869(1-2):56-68. PubMed ID: 10865059
[TBL] [Abstract][Full Text] [Related]
6. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study.
Nemoto C; Hida T; Arai R
Brain Res; 1999 Oct; 846(1):129-36. PubMed ID: 10536220
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
8. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
9. Regulation of GAP-43 protein and mRNA in nigrostriatal dopaminergic neurons after the partial destruction of dopaminergic terminals with intrastriatal 6-hydroxydopamine.
Iwata SI; Nomoto M; Fukuda T
Synapse; 2001 Jan; 39(1):16-22. PubMed ID: 11071705
[TBL] [Abstract][Full Text] [Related]
10. Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
Datla KP; Blunt SB; Dexter DT
Mov Disord; 2001 May; 16(3):424-34. PubMed ID: 11391735
[TBL] [Abstract][Full Text] [Related]
11. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
12. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
Mouatt-Prigent A; Agid Y; Hirsch EC
Brain Res; 1994 Dec; 668(1-2):62-70. PubMed ID: 7704619
[TBL] [Abstract][Full Text] [Related]
13. Calbindin-D 28kD immunofluorescence in ventral mesencephalic neurons labeled following injections of Fluoro-Gold in nucleus accumbens subterritories: inverse relationship relative to known neurotoxin vulnerabilities.
Tan Y; Williams ES; Zahm DS
Brain Res; 1999 Oct; 844(1-2):67-77. PubMed ID: 10536262
[TBL] [Abstract][Full Text] [Related]
14. Relative sparing of calretinin containing neurons in the substantia nigra of 6-OHDA treated rat parkinsonian model.
Kim BG; Shin DH; Jeon GS; Seo JH; Kim YW; Jeon BS; Cho SS
Brain Res; 2000 Feb; 855(1):162-5. PubMed ID: 10650144
[TBL] [Abstract][Full Text] [Related]
15. Effects of a unilateral stereotaxic injection of Tinuvin 123 into the substantia nigra on the nigrostriatal dopaminergic pathway in the rat.
Jackson-Lewis V; Liberatore G
Brain Res; 2000 Jun; 866(1-2):197-210. PubMed ID: 10825495
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
18. GDNF increases the density of cells containing calbindin but not of cells containing calretinin in cultured rat and human fetal nigral tissue.
Meyer M; Zimmer J; Seiler RW; Widmer HR
Cell Transplant; 1999; 8(1):25-36. PubMed ID: 10338273
[TBL] [Abstract][Full Text] [Related]
19. Influence of mesostriatal afferents on the development and transmitter regulation of intrastriatal grafts derived from embryonic striatal primordia.
Liu FC; Dunnett SB; Graybiel AM
J Neurosci; 1992 Nov; 12(11):4281-97. PubMed ID: 1279138
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia.
Grant RJ; Clarke PB
Neuroscience; 2002; 115(4):1281-94. PubMed ID: 12453497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
